Industry Concerned about Roxarsone Withdrawal
US - US Poultry & Egg Association and the National Chicken Council have prepared a letter to the FDA expressing their concern and dissatisfaction regarding the withdrawal of roxarsone from the market, and the potential adverse consequences in terms of food safety, sustainability and additional grain demand.
5 September 2011
2 minute read
The letter to the Commissioner of Food and Drugs at the Food and Drug Administration states:
USPoultry and NCC are writing to share our concerns about the recent suspension of sale of roxarsone animal drug products. In particular, we are concerned that the withdrawal of roxarsone products from the marketplace was not based upon adequate scientific study. We also want to bring to the agency's attention the numerous unintended consequences that are likely to result from the withdrawal of roxarsone products from the marketplace, which include an increased risk of foodborne illness, increased costs due to the need for additional feed, and detrimental environmental impacts resulting from the use of more feed.
To read the full letter from USPoultry and NCC, click here.
